CCTS Newsletter Copy
By: Dane Christiansen, Washington Representative
March 25, 2024
March was a busy month for budget and appropriations activity. Congress sought to complete work on FY 2024 appropriations with final spending bills. The administration released its FY 2025 budget request before the FY 2024 process was completed (flagging policy proposals and priorities, but ensuring the document lacked an accurate comparison between proposed funding and current funding). Advocacy efforts are now fully underway to ensure the largest possible increases for the full spectrum of medical research and key programs during the FY 2025 process.
The administration’s FY 2025 budget request to Congress calls for:
- $3.86 billion in discretionary budget authority for the Food and Drug Administration (FDA).
- $16.64 billion in discretionary budget authority for the Health Resources and Services Administration (HRSA).
- $8.93 billion in discretionary budget authority for the Indian Health Services (IHS).
- $11.51 billion in discretionary budget authority for the Centers for Disease Control and Prevention (CDC).
- $49.79 billion in discretionary budget authority for the National Institutes of Health (NIH) and $50.1 billion in total funding. Most of the proposed additional funding is dedicated to the National Cancer Institute and the Office of the Director with modest increases for most Institutes and Centers.
- $8.16 billion in discretionary budget authority for the Substance Abuse and Mental Health Services Administration (SAMHSA).
- $387 million in discretionary budget authority for the Agency for Healthcare Research and Quality (AHRQ).
The final FY 2024 appropriations bills provide:
- $8.88 billion for the Health Resources and Services Administration, a reduction of $577.19 million from FY 2023.